JapanStake
Pharmaceutical · Fiscal year end Mar 31

Renascience Inc.

4889

株式会社レナサイエンス

FIGI BBG0125DQD124889.T4889 JPCorp. no. 1012301007259

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-12

For the first half of the fiscal year to 2026-03: Ordinary income ¥-0.2 billion, Net income ¥-0.2 billion.

This periodYear on year
Ordinary profit−¥151m—
Net profit to owners−¥152m—

From the securities report on EDINET, which states no forecast. History via /v1/companies/4889/earnings-releases.

Financials

Japan GAAP · non-consolidated · fiscal year to 2026-03-31
Revenue
¥69m
Net income
−¥301m
ROE
—
Equity ratio
94.5%
Dividend / share
—
Employees
3
Revenue · ¥m
FY2022: ¥139m 139 FY2022FY2023: ¥101m 101 FY2023FY2024: ¥194m 194 FY2024FY2025: ¥133m 133 FY2025FY2026: ¥69m 68.6 FY2026
Net income · ¥m
FY2022: −¥254m -254 FY2022FY2023: −¥336m -336 FY2023FY2024: −¥258m -258 FY2024FY2025: ¥113m 113 FY2025FY2026: −¥301m -301 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-03-31¥69m−¥301m¥3,503m¥3,323m—¥-23.39−¥291m
2025-03-31¥133m¥113m¥1,871m¥1,720m6.8%¥8.92−¥176m
2024-03-31¥194m−¥258m¥2,089m¥1,607m—¥-20.32−¥231m
2023-03-31¥101m−¥336m¥2,275m¥1,865m—¥-26.42−¥285m
2022-03-31¥139m−¥254m¥2,438m¥2,201m—¥-22.33−¥230m

Indicators

Computed by us from filings · fiscal year to 2026-03-31
MetricValuePercentile among listed companies
ROE, %——
Ordinary margin-4.38010.5
Equity ratio, %94.599.8
Revenue growth-0.48340.6
Net income growth-3.65613
Operating cash flow / assets-0.08325.7
Policy-uncertainty measure0.50 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Regulation 2
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change −3.69pt in 90 days; 0.2% held by other listed companies.

Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/4889/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-06-23: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断しました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Latest voting result: 2026-06-25 · 定款一部変更の件 · passed. /v1/companies/4889/voting

Ownership changes

All companies →

Trades by 5% holders

From the 60-day trade tables in 5% reports
¥317¥1,219¥2,120 2024-12-162026-09-14 2026-09-14 · sold 263,400 @ ¥1,156 · Heights Capital Management, Inc.2026-03-26 · bought 263,400 @ ¥1,985 · Heights Capital Management, Inc.2026-03-26 · sold 263,400 @ ¥1,692 · Heights Capital Management, Inc.2026-03-05 · bought 263,400 @ ¥1,735 · Heights Capital Management, Inc.2026-01-07 · sold 263,400 @ ¥1,510 · Heights Capital Management, Inc.2026-01-05 · bought 263,400 @ ¥1,562 · Heights Capital Management, Inc.2025-06-10 · sold 600 @ ¥2,100 · DCIパートナーズ株式会社2025-06-09 · sold 100 @ ¥2,120 · DCIパートナーズ株式会社2025-06-05 · sold 100 @ ¥1,890 · DCIパートナーズ株式会社2025-05-22 · sold 100 @ ¥1,865 · DCIパートナーズ株式会社2025-01-28 · sold 700 @ ¥1,540 · DCIパートナーズ株式会社2025-01-27 · sold 300 @ ¥1,313 · DCIパートナーズ株式会社2025-01-17 · sold 400 @ ¥700 · DCIパートナーズ株式会社2025-01-16 · sold 3,200 @ ¥636 · DCIパートナーズ株式会社2025-01-15 · sold 1,200 @ ¥603 · DCIパートナーズ株式会社2024-12-16 · sold 183,300 @ ¥317 · individual filer
Bought SoldHover a dot for the trade
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
Heights Capital Management, Inc.2026-01-05 – 2026-09-28+513,600+3.68pt¥1,606.67¥1,156–1,985
DCIパートナーズ株式会社2021-09-24 – 2025-06-10-1,635,800−12.85pt¥948.99¥603–2,120
individual filer2024-12-16 – 2024-12-16-183,300−1.44pt¥317¥317–317

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4889/trades.

5% filings

Large shareholding reports on 4889
FiledFilerStakeChangeStated purpose
2026-10-05Heights Capital Management, Inc.4.78%−1.87ptpure investment
2026-10-01Heights Capital Management, Inc.6.65%0.00ptpure investment
2026-09-29Heights Capital Management, Inc.6.65%0.00ptpure investment
2026-09-24Heights Capital Management, Inc.6.65%−1.82ptpure investment
2026-05-26Heights Capital Management, Inc.8.47%0.00ptpure investment
2026-05-15Heights Capital Management, Inc.8.47%+1.86ptpure investment
2026-04-02Heights Capital Management, Inc.6.61%+1.02ptpure investment
2026-03-12Heights Capital Management, Inc.5.59%—pure investment
2025-12-19individual filer21.07%−0.46pt—
2025-06-16DCI Partners Co., Ltd.4.59%−1.17ptpure investment

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
— issues
Book value
—
Sold in the year
— — issues
Bought in the year
— — issues
Mutual, both reports
0
Held by listed cos.
2

Held by: TOHOKU CHEMICAL CO., LTD. 7446, DAIICHI SANKYO COMPANY, LIMITED 4568

Purposes, all holdings and mutual flags via /v1/companies/4889/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31
ShareholderSharesRatio
特定有価証券信託受託者 株式会社SMBC信託銀行4,360,60031.65%
individual holder1,470,70010.68%
上田八木短資株式会社300,0002.18%
BNYM SA/NV FOR BNYM FOR BNYM GCM CLIENT ACCTS M ILM FE276,1002.00%
BOFAS INC SEGREGATION ACCOUNT263,4001.91%
楽天証券株式会社共有口189,8001.38%
individual holder173,0001.26%
第一リアルター株式会社156,9001.14%
株式会社SBI証券150,6211.09%
individual holder64,3000.47%

Get this as JSON

GET /v1/companies/4889
GET /v1/companies/4889/financials
GET /v1/companies/4889/details
GET /v1/companies/4889/segments
GET /v1/companies/4889/voting
GET /v1/companies/4889/tender-offers
GET /v1/companies/4889/indicators
GET /v1/companies/4889/earnings-releases
GET /v1/events?ticker=4889
GET /v1/companies/4889/trades         
GET /v1/companies/4889/cross-holdings 
GET /v1/companies/4889/brief          

Plans from $9 a month · Documentation